Table 2.
Pooled prevalence of quality of life and persistent symptoms
| Variable | Studies | Total cases | Cases affected | Pooled prevalence | 95% confidence interval (CI) (%) |
|---|---|---|---|---|---|
| EQ‐VAS | |||||
| Poor quality of life | 7 | 1108 | 539 | 59% | (42–74) |
| 5Q‐5D‐5L | |||||
| Mobility | 5 | 2241 | 401 | 36% | (9–66) |
| Self‐care | 5 | 2241 | 91 | 8% | (1–21) |
| Usual activity | 5 | 2230 | 279 | 28% | (2–65) |
| Pain/discomfort | 5 | 2235 | 683 | 41.5% | (28–55 |
| Anxiety/depression | 5 | 2236 | 680 | 37.5% | (19–58) |
| Persistent symptoms | |||||
| Fatigue | 9 | 2929 | 1787 | 63.9% | (54–73) |
| Dyspnea | 9 | 3278 | 693 | 39.5% | (20–60) |
| Anosmia | 8 | 3194 | 573 | 20% | (15–24) |
| Cough | 7 | 1505 | 333 | 22.5% | (16–30) |
| Sleep disturbances | 4 | 2142 | 759 | 47% | (7–89) |
| Chest pain | 5 | 2497 | 171 | 10% | (5–16) |
| Headache | 5 | 2218 | 175 | 21% | (3–47) |
| Arthralgia | 6 | 2496 | 356 | 24.3% | (14–36) |
| Mental health/PTSD | 3 | 972 | 115 | 14.5% | (4–29) |